UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Critique of the two-fold measure of prediction success for ratios: application for the assessment of drug-drug interactions

Drug metabolism and disposition, 2011-02, Vol.39 (2), p.170-173

2011

Volltextzugriff (PDF)

Optimal Design of Pharmacokinetic Studies

Basic & clinical pharmacology & toxicology, 2010-03, Vol.106 (3), p.250-255

2010

Volltextzugriff (PDF)

Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study

Journal of cerebral blood flow and metabolism, 2011-02, Vol.31 (2), p.439-447

2011

Volltextzugriff (PDF)

A Physiologically Based Pharmacokinetic Model for Strontium Exposure in Rat

Pharmaceutical research, 2013-06, Vol.30 (6), p.1536-1552

2013

Volltextzugriff (PDF)

Phase I Trial of AEG35156 Administered as a 7-Day and 3-Day Continuous Intravenous Infusion in Patients With Advanced Refractory Cancer

Journal of clinical oncology, 2009-04, Vol.27 (10), p.1660-1666

2009

Volltextzugriff (PDF)

Use of Nonlinear Mixed-Effects Analysis for Improved Precision of Early Pharmacodynamic Measures in Tuberculosis Treatment

Antimicrobial Agents and Chemotherapy, 2006-09, Vol.50 (9), p.3154-3156

2006

Volltextzugriff (PDF)

Sequential Population Pharmacokinetic Modeling of Lopinavir and Ritonavir in Healthy Volunteers and Assessment of Different Dosing Strategies

Antimicrobial Agents and Chemotherapy, 2011-06, Vol.55 (6), p.2775-2782

2011

Volltextzugriff (PDF)

Software for population pharmacokinetics and pharmacodynamics

Clinical pharmacokinetics, 1999-04, Vol.36 (4), p.255-264

AARONS, L

1999

Volltextzugriff (PDF)

Pharmacokinetic studies of linezolid and teicoplanin in the critically ill

Journal of antimicrobial chemotherapy, 2005-03, Vol.55 (3), p.333-340

2005

Volltextzugriff (PDF)

Mefloquine Pharmacokinetic-Pharmacodynamic Models: Implications for Dosing and Resistance

Antimicrobial Agents and Chemotherapy, 2000-12, Vol.44 (12), p.3414-3424

2000

Volltextzugriff (PDF)

Pharmacokinetic analysis to assess forgiveness of boosted saquinavir regimens for missed or late dosing

Journal of antimicrobial chemotherapy, 2008-07, Vol.62 (1), p.161-167

2008

Volltextzugriff (PDF)

Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals

Journal of antimicrobial chemotherapy, 2008-12, Vol.62 (6), p.1344-1355

2008

Volltextzugriff (PDF)

How many subjects are necessary for population pharmacokinetic experiments? Confidence interval approach

European journal of clinical pharmacology, 2008-07, Vol.64 (7), p.705-713

2008

Volltextzugriff (PDF)

A semi-mechanistic gastric emptying pharmacokinetic model for 13C-octanoic acid: An evaluation using simulation

European journal of pharmaceutical sciences, 2012-02, Vol.45 (3), p.302-310

2012

Volltextzugriff (PDF)

A population pharmacokinetic model for doxorubicin and doxorubicinol in the presence of a novel MDR modulator, zosuquidar trihydrochloride (LY335979)

Cancer chemotherapy and pharmacology, 2003-02, Vol.51 (2), p.107-118

2003

Volltextzugriff (PDF)

Lumping of whole-body physiologically based pharmacokinetic models

Journal of pharmacokinetics and biopharmaceutics, 1998-02, Vol.26 (1), p.21-46

1998

Volltextzugriff (PDF)

The use of population pharmacokinetics in drug development

Clinical pharmacokinetics, 1996-02, Vol.30 (2), p.81-93

1996

Volltextzugriff (PDF)

A Bayesian method based on clotting factor activity for the prediction of maintenance warfarin dosage regimens

Therapeutic drug monitoring, 2003-02, Vol.25 (1), p.36-40

2003

Volltextzugriff (PDF)

The population pharmacokinetics of R‐ and S‐warfarin: effect of genetic and clinical factors

British journal of clinical pharmacology, 2012-01, Vol.73 (1), p.66-76

2012

Volltextzugriff (PDF)

Quantitative structure-pharmacokinetics relationships : I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat

Journal of pharmacokinetics and biopharmaceutics, 1997-06, Vol.25 (3), p.277-312

1997

Volltextzugriff (PDF)

Population pharmacokinetics and optimal design of paediatric studies for famciclovir

British journal of clinical pharmacology, 2009-10, Vol.68 (4), p.546-560

2009

Volltextzugriff (PDF)

Linking preclinical and clinical whole-body physiologically based pharmacokinetic models with prior distributions in NONMEM

European journal of clinical pharmacology, 2007-05, Vol.63 (5), p.485-498

2007

Volltextzugriff (PDF)

Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers

Journal of antimicrobial chemotherapy, 2009-06, Vol.63 (6), p.1233-1243

2009

Volltextzugriff (PDF)

Structural identifiability analysis and reparameterisation (parameter reduction) of a cardiovascular feedback model: Modelling for Pharmaceutical Sciences

European journal of pharmaceutical sciences, 2012, Vol.46 (4), p.259-271

2012

Volltextzugriff (PDF)

Diazepam pharamacokinetics from preclinical to phase I using a bayesian population physiologically based pharmacokinetic model with informative prior distributions in winbugs

Journal of pharmacokinetics and pharmacodynamics, 2006-10, Vol.33 (5), p.571-594

2006

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(86)

Sprache

Englisch
(86)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(86)
Pharmacology. Drug Treatments
(79)
Science & Technology
(77)
Life Sciences & Biomedicine
(76)
Pharmacology & Pharmacy
(66)
Humans
(63)
Pharmacokinetics
(41)
Male
(38)
Models, Biological
(33)
Female
(28)
Adult
(26)
General Pharmacology
(23)
Middle Aged
(23)
Animals
(19)
Population Pharmacokinetics
(17)
Aged
(15)
Pharmacokinetics. Pharmacogenetics. Drug-Receptor Interactions
(14)
Rats
(14)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(12)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Critique of the two-fold measure of prediction success for ratios: application for the assessment of drug-drug interactions

Optimal Design of Pharmacokinetic Studies

Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study

A Physiologically Based Pharmacokinetic Model for Strontium Exposure in Rat

Phase I Trial of AEG35156 Administered as a 7-Day and 3-Day Continuous Intravenous Infusion in Patients With Advanced Refractory Cancer

Use of Nonlinear Mixed-Effects Analysis for Improved Precision of Early Pharmacodynamic Measures in Tuberculosis Treatment

Sequential Population Pharmacokinetic Modeling of Lopinavir and Ritonavir in Healthy Volunteers and Assessment of Different Dosing Strategies

Software for population pharmacokinetics and pharmacodynamics

Pharmacokinetic studies of linezolid and teicoplanin in the critically ill

Mefloquine Pharmacokinetic-Pharmacodynamic Models: Implications for Dosing and Resistance

Pharmacokinetic analysis to assess forgiveness of boosted saquinavir regimens for missed or late dosing

Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals

How many subjects are necessary for population pharmacokinetic experiments? Confidence interval approach

A semi-mechanistic gastric emptying pharmacokinetic model for 13C-octanoic acid: An evaluation using simulation

A population pharmacokinetic model for doxorubicin and doxorubicinol in the presence of a novel MDR modulator, zosuquidar trihydrochloride (LY335979)

Lumping of whole-body physiologically based pharmacokinetic models

The use of population pharmacokinetics in drug development

A Bayesian method based on clotting factor activity for the prediction of maintenance warfarin dosage regimens

The population pharmacokinetics of R‐ and S‐warfarin: effect of genetic and clinical factors

Quantitative structure-pharmacokinetics relationships : I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat

Population pharmacokinetics and optimal design of paediatric studies for famciclovir

Linking preclinical and clinical whole-body physiologically based pharmacokinetic models with prior distributions in NONMEM

Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers

Structural identifiability analysis and reparameterisation (parameter reduction) of a cardiovascular feedback model: Modelling for Pharmaceutical Sciences

Diazepam pharamacokinetics from preclinical to phase I using a bayesian population physiologically based pharmacokinetic model with informative prior distributions in winbugs

Aktive Filter

Suchergebnisse filtern